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Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen
Timothy F Murphy
Branhamella catarrhalis is now recognised as an called Neisseria catarrhalis because of its similarities in phenotype and ecological niche with important lower respiratory tract pathogen in humans. The recognition of the bacterium as Neisseria species.
B catarrhalis was transferred from Neisseria a human pathogen has been delayed for several reasons: (1) B catarrhalis sometimes colonises to the new genus, Branhamella, in 1970 on the basis of differences in fatty acids content and the upper respiratory tract of children and adults in the absence of infection, so the presence DNA hybridisation studies compared with other Neisseriaceae. 4 An alternative scheme has of the bacterium in sputum does not necessarily establish aetiology in an individual; (2) the Branhamella as a subgenus of Moraxella. 5 Experimental data to support both schemes exist. 6 colony morphology of B catarrhalis is indistinguishable from that of commensal Neis-The name Branhamella catarrhalis is most rational at this time for two reasons: (1) this seria which frequently colonise the human respiratory tract and, as a result, B catarrhalis nomenclature places rod-shaped bacteria (Moraxella) and cocci (Branhamella) in separate has frequently been overlooked in the clinical microbiology laboratory; (3) B catarrhalis species, 7 and (2) B catarrhalis is an important and common human respiratory tract pathocauses relatively non-invasive infections and therefore the organism is seldom recovered gen, whereas Moraxella species are unusual human pathogens. Classifying them in separate from normally sterile body fluids such as blood and pleural fluid.
species emphasises this distinction. The nomenclature of these bacteria continues to be The recognition of B catarrhalis as a significant human respiratory tract pathogen has controversial and further changes may occur. stimulated much interest in clinical and basic research. Knowledge of the epidemiology of infection, the antigenic structure of the bac-Epidemiology and respiratory tract terial surface, and the immune response to colonisation infection are expanding rapidly. 1 This review B catarrhalis has been recovered exclusively will focus on clinical aspects of B catarrhalis from humans. The bacterium colonises primlower respiratory tract infection in adults, in-arily the human respiratory tract although it has cluding epidemiology, clinical manifestations, occasionally been recovered from the genital diagnosis, and treatment.
tract. 8 9 Studies from several centres have assessed the prevalence of colonisation of the upper respiratory tract by B catarrhalis in various populations. A strong relationship between History and nomenclature age and colonisation rates exists. B catarrhalis was first described almost a century ago by Ghon and Pfeiffer 2 and was suspected by Sir William Osler to be the cause of his own terminal pneumonic illness in 1919. 3 
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The organism was subsequently regarded as an About 1-5% of healthy adults are colonised Diseases of the upper respiratory tract commensal until the by B catarrhalis. [10] [11] [12] [13] Infants and children are from 28% of patients with bronchiectasis fol-been implicated as an aetiological agent in such exacerbations. Five principal lines of evidence lowed prospectively in Birmingham, UK. 20 In a prospective study of patients with chronic implicate B catarrhalis in this setting. 24 (1) Using strict criteria to evaluate the quality bronchitis in Buffalo, New York, B catarrhalis has been recovered from approximately 10% of sputum samples, a subset of patients with exacerbations of COPD have sputum smears of sputum samples (author's unpublished observation). These observations suggest that ad-which show a predominance of Gram negative diplococci on Gram strain and nearly pure ults with chronic lung disease are colonised with B catarrhalis at a higher rate than healthy cultures of B catarrhalis. [25] [26] [27] [28] [29] (2) Pure cultures of B catarrhalis have been adults. However, this comparison has not yet been studied rigorously. obtained in transtracheal aspirates from patients experiencing exacerbations and pneumonia. [30] [31] [32] [33] [34] (3) Clinical improvement is seen in patients   Several studies have revealed an increased with B catarrhalis infections following the administration of specific antibiotic therapy. incidence of colonisation and infection caused by B catarrhalis during winter Many penicillins are not active against B catarrhalis because most strains produce months. 11 14 19 21-23 Predisposing viral infection has been proposed as a mechanism for the -lactamase. Patients with -lactamase positive strains who do not respond to seasonal variation of B catarrhalis infections but this is unproved.
-lactam antibiotics show clinical improvement following administration of an antibiotic active against B catarrhalis. 26 29 (4) The organism is occasionally recovered    Two prospective studies have examined the from blood or pleural fluid of patients with evidence of lower respiratory tract infecdynamics of respiratory tract colonisation by B catarrhalis. 15 20 Faden et al 15 followed 120 tion. 27 30 35-38 The recovery of the organism from blood or pleural fluid represents definitive evichildren from birth to two years of age. Restriction endonuclease analysis of genomic dence for an aetiological role of the organism.
Such patients are unusual and represent the DNA from the longitudinally collected strains revealed that children eliminated and acquired most invasive end of the spectrum of disease caused by B catarrhalis. new strains of B catarrhalis frequently. Similarly, Klingman et al 20 studied strains of B catarrhalis (5) Patients with chronic bronchitis who experience exacerbations associated with clinical recovered prospectively from adults with bronchiectasis. Analysis of strains by pulse field gel and laboratory evidence of B catarrhalis infection develop a bactericidal antibody reelectrophoresis of large fragments of genomic DNA demonstrated that the mean duration of sponse to the homologous strain. 25 The observation of a specific immune response to colonisation by individual strains was only 2.3 months.
the organism following clinical infection provides evidence that the bacterium is the cause These studies in two distinct patient populations indicate that colonisation of the upper of the infection.
Taken together, these five lines of evidence respiratory tract by B catarrhalis is a dynamic process with frequent elimination and ac-indicate that B catarrhalis causes lower respiratory tract infection in adults, particularly quisition of new strains.
in those with COPD. It is difficult to estimate the proportion of exacerbations that are due to B catarrhalis. However, one study performed Branhamella catarrhalis as a human pathogen in a Veterans Administration facility found that 30% of exacerbations were caused by B B catarrhalis causes lower respiratory tract infections in adults in three separate but related catarrhalis.
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The clinical manifestations of exacerbations clinical settings: (1) exacerbations in patients with chronic obstructive pulmonary disease caused by B catarrhalis are similar to those of other bacteria such as non-typeable H in-(COPD); (2) pneumonia in the elderly; and (3) more recently it has been recognised as a fluenzae. Exacerbations of COPD are characterised by cough, purulent sputum which is nosocomial respiratory tract pathogen.
In addition to lower respiratory tract in-sometimes copious, and shortness of breath.
When fever is present, it is usually low grade. fections in adults, B catarrhalis is the third most common cause of otitis media in infants and children, based on cultures of middle ear fluid obtained by tympanocentesis.
1 It is also a cause     While it is difficult to state the precise proof sinusitis in children and adults. Finally, invasive infections are a less common mani-portion of pneumonia in the elderly caused by B catarrhalis, studies from centres in Europe festation of infection caused by B catarrhalis. 1 and the United States indicate that the bacterium causes a significant number of these infections. A prospective study estimated that    Non-typeable Haemophilus influenzae and 10% of community acquired pneumonia in the elderly is caused by B catarrhalis. 10 Based on a Streptococcus pneumoniae have long been recognised as causes of purulent exacerbations review of the literature, the mean age of patients with lower respiratory tract infection due to B of COPD. More recently, B catarrhalis has group.bmj.com on May 2, 2017 -Published by http://thorax.bmj.com/ Downloaded from catarrhalis is 64.8 years. 30 A careful study of The detection of bacterial pathogens in sputum by using the polymerase chain reaction carrier rates of B catarrhalis showed that 5.4% of adults under the age of 60 years are colonised (PCR) is increasing in popularity. PCR with primers corresponding to the autolysin gene in with B catarrhalis while 26.5% of adults over the age of 60 years are colonised. 10 These ob-S pneumoniae is a sensitive and specific method for detecting the bacterium in sputum. 65 A servations all indicate that the elderly are at increased risk of respiratory tract infection due study utilising a PCR-based method for detecting B catarrhalis in middle ear fluids into B catarrhalis compared with younger adults.
Most elderly patients who experience pneu-dicates that this approach is likely to be feasible in detecting B catarrhalis in sputum. 66 The monia due to B catarrhalis have underlying cardiopulmonary disease including COPD, potential advantages of PCR-based methods are increased sensitivity and more rapid idenbronchiectasis, congestive heart failure, predisposition to aspiration, and others. 22 30 Other tification of the organism. As with all studies involving sputum, the method will be limited predisposing conditions associated with infection include corticosteroid therapy, diabetes by the quality of the sputum sample. Further study in the next several years will elucidate mellitus, and malignancies. While B catarrhalis pneumonia causes a significant illness in elderly the usefulness of PCR-based methods for the rapid detection of B catarrhalis and other bacpatients, fulminant pneumonia is uncommon. The typical clinical picture is characterised by terial pathogens in sputum. fever as high as 103°F, cough, purulent sputum, and shortness of breath. Auscultation sometimes reveals signs of consolidation. Chest radiography shows either patchy or lobar Treatment About 90% of strains of B catarrhalis produce alveolar infiltrates. Pleural effusion and empyema are uncommon. 22 23 30 41 -lactamase. 67 68 The -lactamase of B catarrhalis is inducible, remains cell associated, is more active against penicillins than cephalosporins, and its activity is inhibited by -    Nosocomial outbreaks of B catarrhalis in-lactamase inhibitors such as clavulanic acid and sulbactam. -lactamase-producing strains fections have been recognised since the mid 1980s.
42-56 Most nosocomial clusters involve show an inoculum-dependent susceptibility to ampicillin so ampicillin should not be used for respiratory tract infections and several of the reported outbreaks have occurred in respiratory -lactamase-producing strains regardless of the results of susceptibility testing. One study units. 45 49 51 52 54 The presence of a population of patients with underlying cardiopulmonary showed persistently positive middle ear cultures during ampicillin therapy for B catarrhalis otitis disease predisposing to B catarrhalis undoubtedly contributes to the nosocomial out-media caused by a -lactamase producing strain. 14 Most B catarrhalis infections can be breaks. Analysis of strains by various typing methods have indicated that some of the clus-treated with orally administered antimicrobial agents. Oral agents active against B catarrhalis ters involved infections with several different strains of B catarrhalis, 52 53 whereas in other include trimethoprim-sulfamethoxazole, tetracycline, ciprofloxacin, azithromycin, clariclusters person to person transmission of B catarrhalis was implicated.
45 54 It will be im-thromycin, extended spectrum cephalosporins, and the combination of amoxicillin and claportant to elucidate the factors responsible for nosocomial clusters so that rational strategies vulanic acid. [67] [68] [69] B catarrhalis is also uniformly susceptible to ticarcillin, piperacillin, mezlofor prevention can be implemented.
cillin, aziocillin, most cephalosporins, chloramphenicol, and aminoglycosides. B catarrhalis is resistant to penicillin, ampicillin, vancomycin, Diagnosis When B catarrhalis is present in the sputum of clindamycin, and methicillin. 70 71 Consideration of the antimicrobial susa patient with lower respiratory tract infection the organism is generally present in large num-ceptibility pattern of B catarrhalis highlights the central role of the sputum Gram strain in bers. 10 A Gram stained sputum sample which shows a predominance of Gram negative dip-guiding the choice of antibiotic, particularly in the treatment of exacerbations of COPD. lococci is highly predictive for the presence of B catarrhalis. 10 26 30 39 57 Indeed, this is the single Ampicillin and amoxicillin are widely used to treat such exacerbations. However, these agents most useful diagnostic test in establishing B catarrhalis lower respiratory tract infection. The are inadequate treatment for B catarrhalis infection. It is therefore important to determine organism tends to resist decolorisation. 58 Characteristic features of the sputum Gram stain whether B catarrhalis is causing the lower respiratory tract infection. Examination of sputum are the abundance of leucocytes, the presence of large numbers of Gram negative diplococci by Gram stain should be performed in patients experiencing exacerbations of COPD, elderly as the exclusive bacterial form, and the presence of intracellular bacteria in leucocytes.
patients with pneumonia, and hospitalised patients with pneumonia. A Gram stained Culture of sputum will confirm the presence of B catarrhalis in sputum and will allow for smear of sputum which reveals a predominance of Gram negative diplococci is highly predictive antimicrobial susceptibility testing of isolates. A variety of commercially available kits is avail-of B catarrhalis as the aetiological agent of the lower respiratory tract infection. In this able to establish the identity of B catarrhalis in the laboratory. [59] [60] [61] [62] [63] [64] circumstance an antimicrobial agent which is 
